1. Home
  2. CYTK vs DUOL Comparison

CYTK vs DUOL Comparison

Compare CYTK & DUOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$68.45

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Logo Duolingo Inc.

DUOL

Duolingo Inc.

HOLD

Current Price

$191.47

Market Cap

8.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYTK
DUOL
Founded
1997
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
8.8B
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
CYTK
DUOL
Price
$68.45
$191.47
Analyst Decision
Strong Buy
Buy
Analyst Count
15
17
Target Price
$77.87
$331.67
AVG Volume (30 Days)
1.9M
2.7M
Earning Date
11-05-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
338.81
EPS
N/A
8.04
Revenue
$87,211,000.00
$964,271,000.00
Revenue This Year
$363.61
$38.90
Revenue Next Year
$64.33
$25.89
P/E Ratio
N/A
$23.82
Revenue Growth
2609.26
39.86
52 Week Low
$29.31
$166.27
52 Week High
$69.33
$544.93

Technical Indicators

Market Signals
Indicator
CYTK
DUOL
Relative Strength Index (RSI) 62.93 35.82
Support Level $59.85 $167.47
Resistance Level $67.98 $192.80
Average True Range (ATR) 2.72 9.46
MACD 0.13 3.71
Stochastic Oscillator 91.35 65.14

Price Performance

Historical Comparison
CYTK
DUOL

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About DUOL Duolingo Inc.

Duolingo Inc is a technology company that develops a mobile learning platform to learn languages and is the top-grossing app in the Education category on both Google Play and the Apple App Store. Its products are powered by sophisticated data analytics and artificial intelligence and delivered with class art, animation, and design to make it easier for learners to stay motivated master new material, and achieve their learning goals. Its solutions include the Duolingo Language Learning App, Super Duolingo, Duolingo English Test: AI-Driven Language Assessment, Duolingo For Schools, Duolingo ABC, and Duolingo Math. It has four predominant sources of revenue; time-based subscriptions, in-app advertising placement by third parties, and the Duolingo English Test, and In-App Purchases.

Share on Social Networks: